VSee Health Q1 EPS $(0.05) Up From $(0.24) YoY, Sales $3.160M Down From $3.321M YoY
VSee Health Q4 EPS $(0.31), Sales $3.926M Up From $3.859M YoY
EXCLUSIVE: Penny Stock VSEE Health Teams Up With GoMyRx To Expand Telehealth Drug Delivery
EXCLUSIVE: VSEE Health Announces Strategic Managed Services Partnership With GoMyRx; Terms Not Disclosed
VSee Health Partners With DocBox To Create Virtual ICU Operating System For Hospitals Globally
VSee Health, Inc. Announces Postponement of Annual Meeting of Stockholders Until December 30, 2025
VSee Health, Inc. Regains Compliance with Nasdaq Stockholders' Equity Requirement
VSee and Novant Health Urgent Care Share Blueprint for Scalable, Profitable Tele-Urgent Programs
VSee Health, Inc. Announces Pricing of $6.0 Million Private Placement Priced At-the-Market Under Nasdaq Rules with a Single Institutional Investor
VSee Health Announces $6M Securities Purchase Agreement For 9.8M Shares And 19.7M Warrants At $0.61
VSee Health's iDoc Division Powers Ahead: Delivering on Major Contracts and Igniting Revenue Growth!
VSee Health Names Dr. Milton Chen as Chairman to Drive AI Infrastructure Growth
VSee Health Appoints Milton Chen Board Chairman
VSEE Health, Inc. Delivers Robust Q3 2025 Revenue Growth Amid Telehealth Expansion: Total Revenues Reach $3.98 Million, Up 19% Year-Over-Year
VSee Health Q3 EPS $(0.02) Beats $(0.11) Estimate, Sales $3.981M Miss $4.228M Estimate
VSee Health Pioneers Telehealth Expansion with FedRAMP Authorization and ICU Robot Integration, Fueling 2025 Growth Surge
VSee Health Leverages FedRAMP Moderate Authorization To Deliver Telehealth Services To Federal Agencies
VSee Engages Philippine Health Leaders and Former VP Robredo in Southeast Asia expansion effort
VSee Health Secures Three-Year Platform Services Agreement with the Region's Sole Level 1 Trauma Center and Academic Health System
Sign up for free to unlock this feature.
Creating your account...
Your account has been created. Redirecting...
Loading...
This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.